Genmab A/S (GMAB) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Genmab A/s.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.335 -- 00:00:05.382 Hello and welcome to the GENmaps financial results conference call for the first quarter 00:00:05.382 -- 00:00:09.609 of 2025. As a reminder, this conference call is being recorded. 00:00:09.609 -- 00:00:14.236 During this telephone conference, you may be presented with forward-looking statements 00:00:14.236 -- 00:00:19.163 that include words such as beliefs, anticipates, plans or expects. 00:00:19.163 -- 00:00:23.730 Actual results may differ materially, for example, as a result of delayed or unsuccessful 00:00:23.730 -- 00:00:28.921 development projects. GENmaps is not under any obligation to update 00:00:28.921 -- 00:00:33.388 statements regarding the future, not to confirm such statements in relation to actual 00:00:33.388 -- 00:00:38.916 results, unless this is required by law. Please also note that GENMAP 00:00:38.916 -- 00:00:44.164 may hold your personal data as indicated by you as a part of our investor relations outreach 00:00:44.164 -- 00:00:48.631 activities in order to update you on GENMAP going forward. 00:00:48.631 -- 00:00:54.520 Please refer to our website for more information on GENMAP and our privacy policy. 00:00:54.520 -- 00:00:58.824 I would now like to hand the conference over to our first speaker today, Jan van de Winkel. 00:00:58.824 -- 00:01:01.184 Please go ahead. 00:01:01.426 -- 00:01:05.250 Hello, and welcome to GenMob's conference call to discuss our financial results for the 00:01:05.250 -- 00:01:09.512 period ending March 31st, 2025. 00:01:09.574 -- 00:01:14.178 With me today to present these results is our Chief Financial Officer, Anthony Pagano, 00:01:14.178 -- 00:01:19.583 our Chief Commercial Officer, Brad Bailey, and our Chief Medical Officer, Tai Yamadi. 00:01:19.583 -- 00:01:25.266 For the Q&...